Recent health news highlights include a halt in new measles cases in Texas, efforts to accelerate the approval of drugs for ...

The EU faces a surge in new opioids and designer drugs, while the U.S. fast-tracks rare disease drugs. Brazil tackles bird ...

Omada Health shows strong growth and innovation in chronic care but remains unprofitable with valuation, churn. See why OMDA ...

Two sizable issuers went public this past week and featured the best first-day pop for a billion-dollar IPO in Renaissance’s ...

The IPO market is starting to feel healthier. Omada Health, a 14-year-old company providing virtual care for chronic ...